Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report
Mev Dominguez–Valentin(Norwegian Cancer Society), Adriana Della Valle(Hospital Central de las Fuerzas Armadas), Emma J. Crosbie(University of Manchester), Claudia Perne(University of Bonn), Revital Kariv(Tel Aviv University), Stefan Aretz(University of Bonn), Karl Heinimann(University Hospital of Basel), John Burn(Newcastle University), Sigve Nakken(Oslo University Hospital), Giulia Martina Cavestro(University of Parma), Christoph Engel(University Hospital Leipzig), Neil Ryan(University of Edinburgh), Gabriel Capellá(Institut Català d'Oncologia), Lucio Bertario(European Institute of Oncology), Guy Rosner(Tel Aviv University), Wouter H. de Vos tot Nederveen Cappel(Isala), Tamara Alejandra Piñero(Hospital Italiano de Buenos Aires), Johanna Tecklenburg(Medizinische Hochschule Hannover), Huw Thomas(St Mark's Hospital), Elke Holinski‐Feder(Garvan Institute of Medical Research), Pablo Kalfayan, Maartje Nielsen(University Medical Center Groningen), Nathan Gluck(Tel Aviv University), Marc S. Greenblatt(University of Vermont), Jukka‐Pekka Mecklin(University of Jyväskylä), Inge Bernstein(Aalborg University Hospital), Finlay Macrae(The Royal Melbourne Hospital), John‐Paul Plazzer(University of Vermont), Kate Green(University of Manchester), Lone Sunde(Aalborg University Hospital), Verena Steinke‐Lange(University of Cambridge), Ingrid Winship, Sanne W. ten Broeke(Leiden University Medical Center), Bernardo Bonanni(European Institute of Oncology), Rolf H. Sijmons(University Medical Center Groningen), Marta Pineda(University of Surrey), Deepak Vangala(Universitätsklinikum Knappschaftskrankenhaus Bochum), Eivind Hovig(Oslo University Hospital), Carlos Vaccaro(Hospital Italiano de Buenos Aires), Mark A. Jenkins(The University of Melbourne), Wolff Schmiegel(Universitätsklinikum Knappschaftskrankenhaus Bochum), María Laura González, James Hill(Manchester University NHS Foundation Trust), Hans-Georg Strauß(Martin Luther University Halle-Wittenberg), Matilde Navarro(Institut d'Investigació Biomédica de Bellvitge), Fiona Lalloo(Manchester Academic Health Science Centre), Lior H. Katz(Sheba Medical Center), Maria Grazia Tibiletti(University of Insubria), Miriam Mints(Karolinska University Hospital)
Cited by 44
Related Papers
Mutation of a <i>mutL</i> Homolog in Hereditary Colon Cancer
|Science|1994|1.8k
Association analysis identifies 65 new breast cancer risk loci
|Nature|2017|1.6k
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
|The American Journal of Human Genetics|2018|1.2k